Timothy Kuzel, MD
Enriched profileMedical Director, Northwestern Medicine St. George Cancer Institute · Northwestern University
Timothy Kuzel is Medical Director, Northwestern Medicine St. George Cancer Institute at Northwestern University. OpenAlex indexes 340 publications with 19,675 citations (h-index 67); ClinicalTrials.gov lists 13 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Timothy Kuzel, MD, is Medical Director, Northwestern Medicine St. George Cancer Institute at Northwestern University (Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center). The public record shows 340 publications with 19,675 citations (h-index 67), centered on Cutaneous lymphoproliferative disorders research, Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 18 companies, 5 NIH-funded awards (1990–2013).
- Most recent indexed publication: 2025 · Journal of clinical oncology
- Top research focus: Cutaneous lymphoproliferative disorders research
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 18 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 176.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- Low-moderate Intensity Pedaling During Immunotherapy Administration
Sponsor: Rush University Medical Center
- Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Sponsor: Northwestern University
- Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL
Sponsor: Northwestern University
Industry payments
Updated 27 Aug 2026
18 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202513 payments$21,470openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202511 payments$12,892openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
33.6%Corticosteroid18%Prednisone100%Part D≥44 patientsSerotonin-3 Receptor Antagonist15.6%Palonosetron hcl79%Ondansetron Hcl21%Part D + Part B≥13 patientsSensory organs
19.7%Corticosteroid19.7%Dexamethasone sodium phosphate91%Dexamethasone9%Part D + Part B<11 patientsCancer & immunology
18.5%Cytochrome P450 17A1 Inhibitor5.7%Abiraterone Acetate100%Part D≥13 patientsKinase inhibitor5.5%Cabometyx33%Balversa24%Cotellic24%Lenvima19%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
5 NIH research awards on record, funded 1990–2013 per NIH RePORTER. The latest:
Congress activity
Updated 27 Aug 2026
57 congress contributions (2004–2026) across AACR, ASCO, ASH, ASTRO per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.
Journal of clinical oncology
Clinical Trial2025 - Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway).
Clinical cancer research
Clinical Trial2024 - Gut Microbial Shifts Indicate Melanoma Presence and Bacterial Interactions in a Murine Model.
Diagnostics (Basel, Switzerland)
Article2022 - CrkII/Abl phosphorylation cascade is critical for NLRC4 inflammasome activity and is blocked by Pseudomonas aeruginosa ExoT.
Nature communications
Article2022
Most-cited works
by citation count (OpenAlex)- 01Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II TrialArticle1,083 citations2014
- 02
- 03gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced MelanomaArticle895 citations2011
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/timothy-kuzel-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/tlmothy-kuzel-md-facp-9231b81a
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Timothy-Kuzel
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- X / Twitter
x.com/ASCO/status/1395458056306188289
- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
- Board Certified
Internal Medicine (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗ - Board Certified
Medical Oncology (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Editorial & leadership roles
journal and society appointments- Fellow
American College of Physicians (FACP)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →expertinstitute.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →patientdaily.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →allianceforclinicaltrialsinoncology.org ↗
Secondary affiliations
appointments beyond the home institution- Rush University
Rush Medical College - Samuel G. Taylor III Professor of Oncology; Chief, Division of Hematology/Oncology/Cell Therapy
2016verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗ - Clinical Professor
Medicine (Hematology and Oncology), Northwestern University Feinberg School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →targetedonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University
Philip Greenland, MD
Northwestern University
Peter Kahrilas, MD
Northwestern University
Philip Gorelick, MD
Northwestern University